Ignite Creation Date:
2024-05-06 @ 8:36 AM
Last Modification Date:
2024-10-26 @ 12:02 PM
Study NCT ID:
NCT02773459
Status:
COMPLETED
Last Update Posted:
2019-09-30
First Post:
2016-05-13
Brief Title:
MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer
Sponsor:
Seoul National University Hospital
Organization:
Seoul National University Hospital
Organization Data
Organization:
Seoul National University Hospital
Class:
OTHER
Study ID:
BTC-MEK162
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Seoul National University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None